APA (7th ed.) Citation

K, C., MF, A., CM, A., K, B., RR, B., D, B., . . . M, B. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes care, 48(7), 1057. https://doi.org/10.2337/dci24-0094

Chicago Style (17th ed.) Citation

K, Cusi, et al. "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association." Diabetes Care 48, no. 7 (2025): 1057. https://doi.org/10.2337/dci24-0094.

MLA (9th ed.) Citation

K, Cusi, et al. "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association." Diabetes Care, vol. 48, no. 7, 2025, p. 1057, https://doi.org/10.2337/dci24-0094.